piracetam and Diffuse Myofascial Pain Syndrome studies

piracetam and Diffuse Myofascial Pain Syndrome

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Research Excerpts

Excerpt	Relevance	Reference
"Erythrocyte transketolase activity coefficient (ETK-AC) and affinity for coenzyme (Km TPP) were assessed in 50 patients with transketolase abnormalities such as fibromyalgia or senile dementia of Alzheimer's type, before and after magnesium (Mg), thiamin+pyridoxine (B1,B6), high energy phosphates (HEP) (phosphocreatinine of adenosine triphosphate), and piracetam."	3.69	Effects of magnesium, high energy phosphates, piracetam and thiamin on erythrocyte transketolase. ( Arroyo, P; Ayavou, T; Bagneres, D; Eisinger, J; Plantamura, A, 1994)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (33.33)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (66.67)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Üçeyler, N	2
Sommer, C	2
Walitt, B	2
Häuser, W	2
Eisinger, J	1
Bagneres, D	1
Arroyo, P	1
Plantamura, A	1
Ayavou, T	1

Studies

Üçeyler, N

Sommer, C

Walitt, B

Häuser, W

Eisinger, J

Bagneres, D

Arroyo, P

Plantamura, A

Ayavou, T

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179]	Phase 3	200 participants (Anticipated)	Interventional	2021-03-01	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Cannabidiol for Fibromyalgia -The CANNFIB Trial Protocol for a Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-center Trial[NCT04729179]

Phase 3

200 participants (Anticipated)

Interventional

2021-03-01

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for piracetam and Diffuse Myofascial Pain Syndrome

Article	Year
WITHDRAWN: Anticonvulsants for fibromyalgia. The Cochrane database of systematic reviews, 2017, 10-09, Volume: 10 Topics: Acetamides; Amines; Anticonvulsants; Conflict of Interest; Cyclohexanecarboxylic Acids; Fibromyalgia	2017
Anticonvulsants for fibromyalgia. The Cochrane database of systematic reviews, 2013, Oct-16, Issue:10 Topics: Acetamides; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Fibromyalgia; Gabapentin; gamma-Am	2013

Article

Year

WITHDRAWN: Anticonvulsants for fibromyalgia.

The Cochrane database of systematic reviews, 2017, 10-09, Volume: 10

Topics: Acetamides; Amines; Anticonvulsants; Conflict of Interest; Cyclohexanecarboxylic Acids; Fibromyalgia

2017

Anticonvulsants for fibromyalgia.

The Cochrane database of systematic reviews, 2013, Oct-16, Issue:10

Topics: Acetamides; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Fibromyalgia; Gabapentin; gamma-Am

2013

Other Studies

1 other study available for piracetam and Diffuse Myofascial Pain Syndrome

Article	Year
Effects of magnesium, high energy phosphates, piracetam and thiamin on erythrocyte transketolase. Magnesium research, 1994, Volume: 7, Issue:1 Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Erythrocytes; Female; Fibromyalg	1994

Article

Year

Effects of magnesium, high energy phosphates, piracetam and thiamin on erythrocyte transketolase.

Magnesium research, 1994, Volume: 7, Issue:1

Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Erythrocytes; Female; Fibromyalg

1994